Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Mar 1;32(3):434-439.
doi: 10.1093/ndt/gfw064.

Renal effects of novel antiretroviral drugs

James Milburn  1 , Rachael Jones  2 , Jeremy B Levy  1
Affiliations
Review

Renal effects of novel antiretroviral drugs

James Milburn et al. Nephrol Dial Transplant. .

Abstract

Chronic kidney disease (CKD) is a critical comorbidity for patients living with HIV, with an estimated prevalence between 2.4 and 17%. Such patients are increasingly affected by diseases associated with ageing, including cardiovascular disease and CKD, and the prevalence of risk factors such as smoking and dyslipidaemia is increased in this population. Proteinuria is also now recognized as a common finding in individuals living with HIV. While combination antiretroviral (ARV) treatments reduce CKD in the HIV-infected population overall, some ARV drugs have been shown to be nephrotoxic and associated with worsening renal function. Over the last few years, several highly efficacious new ARV agents have been introduced. This brief review will look at the novel agents dolutegravir, raltegravir, elvitegravir, cobicistat, tenofovir alafenamide fumarate and atazanavir, all of which have been licensed relatively recently, and describe issues relevant to renal function, creatinine handling and potential nephrotoxicity. Given the prevalence of CKD, the wide range of possible interactions between HIV, ARV therapy, CKD and its treatments, nephrologists need to be aware of these newer agents and their possible effect on kidneys.

Keywords: HIV; acute kidney injury; creatinine; proteinuria.

PubMed Disclaimer

References

    1. May MT, Gompels M, Delpech V et al. . Impact of life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy. AIDS 2014; 28: 1193–1202 - PMC - PubMed
    1. Mdodo R, Frazier EL, Dube SR et al. . Cigarette smoking prevalence among adults with HIV compared with the general adult population in the United States: cross-sectional surveys. Ann Intern Med 2015; 162: 335–344 - PubMed
    1. Pedersen KK, Pedersen M, Trøseid M et al. . Microbial translocation in HIV infection is associated with dyslipidemia, insulin resistance, and risk of myocardial infarction. J Acquir Immune Defic Syndr 2013; 64: 425–433 - PubMed
    1. Ryom L, Kirk O, Lundgren JD et al. . Advanced chronic kidney disease, end-stage renal disease and renal death among HIV-positive individuals in Europe. HIV Med 2013; 14: 503–508 - PubMed
    1. Cambell LJ, Ibrahim F, Fisher M et al. . Spectrum of chronic kidney disease in HIV-infected patients. HIV Med 2009; 10: 329–336 - PubMed

MeSH terms